Evidence map›Paper›PMID 42819055›Full record

ArticleFrontiers in medicine2026

Presumed

Tian Jingjing, Ye Nannan, Zhai Jingjie, Cui Ping, Zhang Yankun

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tian JingjingDepartment of Ophthalmology, Hebei Chest Hospital, Shijiazhuang, China.
Ye NannanDepartment of Ophthalmology, Hebei Chest Hospital, Shijiazhuang, China.
Zhai JingjieDepartment of Ophthalmology, Hebei Chest Hospital, Shijiazhuang, China.
Cui PingDepartment of Ophthalmology, Hebei Chest Hospital, Shijiazhuang, China.
Zhang YankunDepartment of Ophthalmology, Hebei Chest Hospital, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Endophthalmitis is a kind of infectious diseases that seriously threatens vision; Endogenous fungal endophthalmitis (EFE) accounts for 2% to 8% of all endophthalmitis, and is rare and often misdiagnosed in clinical practice. Different strains of Case report: A 72 year old male patient was admitted to the hospital due to fever for 5 months and decreased vision in both eyes. The patient's left vitreous fluid underwent metagenomic next-generation sequencing (mNGS), which revealed the presence of Conclusion: EFE is prone to misdiagnosis, and high-risk individuals should undergo pathogen testing as soon as possible. mNGS is a rapid identification tool, but caution should be exercised when single sequence detection and negative culture occur. When the pathogens are inconsistent, alternative explanations such as contamination and sequential infection should be excluded. The combination of comprehensive antifungal therapy and surgical treatment is effective,Clinical physicians need to establish a global mindset and pay attention to the intrinsic relationship between systemic lesions and eye damage.

Indexed as

Candida albicansCandida tropicalisendogenous fungal endophthalmitismetagenomic next-generation sequencingvitrectomy

Identifiers

PMID42819055
PMCPMC13623556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.